Gaba-P CR 330 Cr Tablet

About Gaba-P CR 330 Cr Tablet

Gaba-P CR 330 is a controlled-release tablet containing pregabalin 330 mg, made by Renata PLC. Pregabalin belongs to a group of medicines used as an adjunct anti-epileptic drug and is also prescribed for certain types of nerve pain.

There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Gaba-P CR 330 Cr Tablet?

Gaba-P CR 330 is a controlled-release tablet that contains pregabalin 330 mg. Pregabalin works in the central nervous system, and its exact way of acting is not fully understood; it is thought to attach to a specific site on calcium channels in nerve tissue. It is classed as an adjunct anti-epileptic medicine, meaning it is used alongside other treatment rather than alone for seizures. It is also used for some kinds of nerve pain and for other conditions your doctor may identify. The controlled-release form is taken differently from ordinary capsules, so follow the doctor's directions. The doctor decides the dose and how long you take it.

Uses of Gaba-P CR 330

Pregabalin is used for nerve pain linked to diabetes and for pain after shingles. It is also used as add-on treatment for partial-onset seizures, for fibromyalgia, and for nerve pain from spinal cord injury. Gaba-P CR 330 is the controlled-release tablet form. Whether it suits your condition, and how it fits with your other medicines, is a decision for your doctor. Ask your doctor or pharmacist if you are unsure why it has been prescribed for you.

How to use Gaba-P CR 330

Swallow the controlled-release tablet as your doctor or pharmacist instructs. Do not crush, split or chew it unless you are told to, because it is made to release the medicine over time. The doctor decides the dose and the course; never change it yourself. If you miss a dose, ask your pharmacist what to do rather than doubling up. Do not stop suddenly on your own, as the doctor will advise how to stop safely. Keep the tablet in a cool, dry place below 30°C, away from light and moisture, and out of reach of children.

Side effects of Gaba-P CR 330

Common side effects in adults include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain and difficulty concentrating. In children treated for partial-onset seizures, increased weight and increased appetite are common. Tell your doctor if these bother you or do not settle. Seek urgent help for swelling of the throat, head or neck, or for hives, breathing difficulty or wheezing, as these need immediate attention. Your doctor or pharmacist can explain what else to watch for.

Safety and precautions

Do not take Gaba-P CR 330 if you have had an allergic reaction to pregabalin or any of its ingredients. Swelling of the throat, head or neck, and reactions such as hives or wheezing, mean the medicine should be stopped and help sought at once. Antiepileptic medicines, including pregabalin, can raise the risk of suicidal thoughts or behaviour, so tell your doctor about mood changes. Breathing problems can occur when it is taken with other medicines that depress the central nervous system, or if you already have breathing problems. There are no adequate studies in pregnant women, so pregnancy should be discussed with the doctor, and breastfeeding is not recommended during treatment. Ask your doctor first if you are pregnant, planning pregnancy, breastfeeding, or have kidney or breathing problems.

Frequently asked questions

What does the generic name pregabalin mean?

Pregabalin is the generic name of the active ingredient. It is a structural derivative of GABA, a natural inhibitory chemical in the body, but it does not attach directly to GABA receptors. Instead it binds to a site on certain calcium channels in the nervous system. The brand name Gaba-P CR 330 is specific to this manufacturer.

What is Gaba-P CR 330 used for, and what kind of medicine is it?

It is an adjunct anti-epileptic medicine, used as add-on treatment for partial-onset seizures. Pregabalin is also used for certain nerve pain conditions, fibromyalgia and nerve pain after spinal cord injury. Gaba-P CR 330 is a controlled-release 330 mg tablet. Your doctor will confirm whether it is right for your condition.

Which medicines may interact with Gaba-P CR 330?

Pregabalin is unlikely to cause significant pharmacokinetic drug interactions. However, breathing problems may occur when it is taken with other medicines that depress the central nervous system, or if you already have breathing problems. Tell your doctor and pharmacist about every medicine you take, including ones bought without a prescription, so your treatment can be checked.

Can I stop taking Gaba-P CR 330 on my own?

Do not stop or change the dose without speaking to your doctor. The doctor decides the dose and course of treatment and can advise how to stop safely. If you have missed a dose or want to stop, ask your doctor or pharmacist rather than making changes yourself. Also check with them before crushing or splitting the tablet.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Asibalin Capsule

25 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ 7.84 ৳ 8.00 2% off per unit

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 10.78 ৳ 11.00 2% off per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 11.76 ৳ 12.00 2% off per unit

Asibalin Capsule

50 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ 11.76 ৳ 12.00 2% off per unit

Broklin Capsule

50 mg

Pregabalin

One Pharma Ltd.

৳ 12.74 ৳ 13.00 2% off per unit

Neugalin Capsule

50 mg

Pregabalin

The ACME Laboratories Ltd.

৳ 14.31 ৳ 14.6 2% off per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.